Results
eNauka >
Results >
FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: a randomized phase II CECOG study
| Title: | FOLFOX4 plus cetuximab administered weekly or every second week in the first-line treatment of patients with KRAS wild-type metastatic colorectal cancer: a randomized phase II CECOG study | Authors: | Brodowicz, T.; Ciuleanu, T.E.; Radosavljević, Davorin   ; Shacham-Shmueli, E.; Vrbanec, D.; Plate, S.; Mrsic-Krmpotic, Z.; Dank, M.; Purkalne, G.; Messinger, D.; |
Issue Date: | 2013 | Publication: | Annals of Oncology. ESMO 2013. | ISSN: | 0923-7534 Annals of Oncology Search Idenfier |
Publisher: | European Society for Medical Oncology. ESMO. Elsevier Inc. | Type: | Article | Collation: | vol. 24 br. 7 str. 1769-1777 | DOI: | 10.1093/annonc/mdt116 | WoS-ID: | 000321881600009 | Scopus-ID: | 2-s2.0-84882798781 | URI: | https://enauka.gov.rs/handle/123456789/268618 | URL: | https://pubmed.ncbi.nlm.nih.gov/23559149/ https://www.annalsofoncology.org/action/showPdf?pii=S0923-7534%2819%2936658-X |
Metadata source: | Migrirano iz RIS podataka | M-category: | 21aM21a |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.